ORCA TherapeuticsORCA Therapeutics
  • HOME
  • COMPANY
    • Partners
    • Executive Summary
  • PEOPLE
    • Kees Groen, CEO
    • Jan van der Hoeven, CFO
    • Victor van Beusechem, CSO
    • Wenliang Dong, COO
    • Scientific Advisory Board
  • PIPELINE
    • Technology
    • ORCA-010
    • P53 Functions
    • RNA Interference
    • Scientific Publications
  • HORIZON2020
  • NEWS
  • CONTACT
  • HOME
  • COMPANY
    • Partners
    • Executive Summary
  • PEOPLE
    • Kees Groen, CEO
    • Jan van der Hoeven, CFO
    • Victor van Beusechem, CSO
    • Wenliang Dong, COO
    • Scientific Advisory Board
  • PIPELINE
    • Technology
    • ORCA-010
    • P53 Functions
    • RNA Interference
    • Scientific Publications
  • HORIZON2020
  • NEWS
  • CONTACT

People

Kees Groen, Ph.D.

Kees Groen, Ph.D.

Chief Executive Officer (CEO)

Jan van der Hoeven, MSc

Jan van der Hoeven, MSc

Chief Financial Officer (CFO)

Professor Victor van Beusechem, Ph.D.

Professor Victor van Beusechem, Ph.D.

Chief Scientific Officer (CSO)

Wenliang Dong, Ph.D.

Wenliang Dong, Ph.D.

Chief Operational Officer (COO)

Janneke Meulenberg, Ph.D.

Janneke Meulenberg, Ph.D.

Ramon Alemany, Ph.D.

Ramon Alemany, Ph.D.

Prof. Winald Gerritsen, MD, Ph.D.

Prof. Winald Gerritsen, MD, Ph.D.

Prof. Frank McCormick, Ph.D.

Prof. Frank McCormick, Ph.D.

Prof. Robert Rodriguez, MD, Ph.D.

Prof. Robert Rodriguez, MD, Ph.D.

https://hrvatskafarmacija24.com

© 2023 ORCA Therapeutics. B.V. All Rights Reserved